Crescent Biopharma Inc
F:C68
Crescent Biopharma Inc
F:C68
Price:
16
EUR
0.63%
Market Cap:
€222.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Crescent Biopharma Inc
F:C68
|
US |
|
Lotus Resources Ltd
OTC:LTSRF
|
AU |
|
Kardex Holding AG
OTC:KRDXF
|
CH |
|
E-World Co Ltd
KRX:084680
|
KR |
|
Roche Holding AG
SIX:RO
|
CH |
|
H
|
Hoa Binh Construction Group JSC
VN:HBC
|
VN |
|
Comms Group Ltd
ASX:CCG
|
AU |
|
Ross Group PLC
LSE:RGP
|
UK |
|
ENB Financial Corp
OTC:ENBP
|
US |
|
Micropole SA
PAR:ALMIC
|
FR |
Multiples-Based Value
The
Multiples-Based Value for
Crescent Biopharma Inc (C68)
under the Base Case is
hidden
EUR.
Compared with the current market price of 16 EUR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
C68 Multiples-Based Value
LOCKED
Multiples Across Competitors
C68 Competitors Multiples
Crescent Biopharma Inc Competitors
Crescent Biopharma Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Crescent Biopharma Inc
F:C68
|
222.2m EUR | 23.6 | -1.6 | -0.3 | -0.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD | 6 | 87.2 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD | 5 | 23.7 | 13.8 | 13.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.3B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.7B USD | 9.1 | 27.7 | 20.8 | 21.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.4B USD | 5.6 | 17.8 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3 | 33.6 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR | 11.6 | 37.4 | 40.8 | 41.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
